Virtual and decentralized clinical trials have been a promise for many for a number of years now, and whilst there have been an increasing number of successes, plans have often been frustrated by operational, tech and regulatory challenges. However, in 2020, the COVID-19 pandemic and associated lockdowns have accelerated the use of virtual, decentralized and hybrid trials.
We are conducting one of the biggest surveys of its kind across clinical trials professionals from pharma/biotech, CROs, sites, service providers, consultancies, academia and patient groups around the world. The final report will reveal unique insights into the use of virtual, decentralized and hybrid trials today and the strategy for adoption in the future.
Completing the survey will take just 5 minutes and will give you exclusive early access to the final report. All answers will remain anonymous.